CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth.
暂无分享,去创建一个
F. Ionna | G. Pirozzi | G. Ruggiero | D. Zanzi | M L Lombardi | G Pirozzi | V Lombari | D Zanzi | F Ionna | S Errico | G Ruggiero | C Manzo | V. Lombari | M. Lombardi | S. Errico | C. Manzo | Giuseppe Pirozzi | Franco Ionna | Maria Luisa Lombardi | Ciro Manzo
[1] J. Bonnefoy,et al. CD40 ligand is functionally expressed on human eosinophils , 1995, European journal of immunology.
[2] R. Flavell,et al. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.
[3] C. Janeway,et al. Signals and signs for lymphocyte responses , 1994, Cell.
[4] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[5] S. Ferrone,et al. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. , 1993, Cancer research.
[6] R. V. van Lier,et al. Induction of T cell proliferation with anti‐CD3 switch‐variant monoclonal antibodies: effects of heavy chain isotype in monocyte‐dependent systems , 1987, European journal of immunology.
[7] I. Stamenkovic,et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.
[8] R. Flavell,et al. An essential role for gp39, the ligand for CD40, in thymic selection , 1995, The Journal of experimental medicine.
[9] J. Banchereau,et al. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. , 1997, Journal of immunology.
[10] P. Hersey,et al. Expression of the co‐stimulatory molecule CD40 on melanoma cells , 1996 .
[11] R. V. van Lier,et al. CD27: marker and mediator of T-cell activation? , 1994, Immunology today.
[12] S. Fortune,et al. Ligation of CD40 on fibroblasts induces CD54 (ICAM‐1) and CD106 (VCAM‐1) up‐regulation and IL‐6 production and proliferation , 1995, Journal of leukocyte biology.
[13] E. Clark,et al. Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.
[14] S. Ferrone. Melanoma, immune surveillance, and immunotherapy. , 1994, The Journal of clinical investigation.
[15] K P Lee,et al. Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.
[16] H. Spits,et al. CD40 expressed on thymic epithelial cells provides costimulation for proliferation but not for apoptosis of human thymocytes. , 1996, Journal of immunology.
[17] P. Linsley,et al. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7. , 1993, Journal of immunology.
[18] W. Fanslow,et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.
[19] H. Stein,et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease , 1992, Cell.
[20] H. Ploegh,et al. Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.
[21] J. Simon,et al. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. , 1999, Cancer research.
[22] G. Freeman,et al. Isolated human follicular dendritic cells display a unique antigenic phenotype , 1989, The Journal of experimental medicine.
[23] J. Banchereau,et al. Functions of CD40 on B cells, dendritic cells and other cells. , 1997, Current opinion in immunology.
[24] V. Cerundolo,et al. An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions , 1999, The Journal of experimental medicine.
[25] H. Engelmann,et al. A novel function of CD40: induction of cell death in transformed cells , 1996, The Journal of experimental medicine.
[26] M. Jenkins,et al. Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction. , 1994, Journal of immunology.
[27] Tumor antigens. , 1981, The New England journal of medicine.
[28] P. Kiener,et al. Expression of functional CD40 by vascular endothelial cells , 1995, The Journal of experimental medicine.
[29] R. Flavell,et al. CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.
[30] L. Davis,et al. The CD40 ligand expressed by human B cells costimulates B cell responses. , 1995, Journal of immunology.
[31] H. Spits,et al. A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction , 1997, The Journal of experimental medicine.
[32] E. Danen,et al. Establishment and characterization of an uveal‐melanoma cell line , 1995, International journal of cancer.
[33] S. Rosenberg,et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. , 1994, Journal of the National Cancer Institute.
[34] L. Lanier,et al. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes , 1992, The Journal of experimental medicine.
[35] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[36] K. Kishi,et al. Induction of human IgE synthesis in B cells by mast cells and basophils , 1993, Nature.
[37] R. Noelle,et al. The role of CD40 in the regulation of humoral and cell-mediated immunity. , 1994, Immunology today.
[38] G. Freeman,et al. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. , 1994, Journal of immunology.
[39] T. Boon,et al. Tumor antigens recognized by T lymphocytes , 1997, International journal of clinical & laboratory research.
[40] B. Seed,et al. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. , 1991, Journal of immunology.
[41] R. V. van Lier,et al. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death. , 1996, Journal of immunology.
[42] D. Gray,et al. CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.
[43] H. Spits,et al. CD40 is functionally expressed on human thymic epithelial cells. , 1992, Journal of immunology.
[44] Terry Farrah,et al. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.
[45] T. Kipps,et al. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal , 1993, The Journal of experimental medicine.
[46] S. Paulie,et al. Stimulation of CD40 in human bladder carcinoma cells inhibits anti‐FAS/APO‐1 (CD95)‐induced apoptosis , 1998, International journal of cancer.
[47] P. Borrow,et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response , 1996, The Journal of experimental medicine.
[48] Alejandro Aruffo,et al. CD40 is functionally expressed on human keratinocytes , 1996, European journal of immunology.
[49] L. Lanier,et al. CD40 preferentially costimulates activation of CD4+ T lymphocytes. , 1994, Journal of immunology.
[50] P. Linsley,et al. Costimulation of T cells for tumor immunity. , 1993, Immunology today.
[51] D. Choy,et al. Nasopharyngeal carcinoma and lymphoinfiltration. , 1991, Oncology.
[52] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[53] R. Looney,et al. CD40 expression by human fibroblasts. , 1995, Clinical immunology and immunopathology.
[54] R. Callard,et al. CD40 ligand and its role in X-linked hyper-IgM syndrome. , 1993, Immunology today.
[55] L. Lanier,et al. Multicolor immunofluorescence and flow cytometry , 1991 .
[56] R. Noelle,et al. CD40 and its ligand in host defense. , 1996, Immunity.
[57] E. Clark,et al. CD40: a cytokine receptor in search of a ligand. , 1990, Tissue antigens.